Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-23

Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effectiveness and safety of a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with essential hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilsartan medoxomil (azilsartan medoxomil)
  • Chlorthalidone (chlorthalidone)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-04-23